Prevention of preterm birth

Women's Health

Volumn 4, Issue 6, 2008, Pages 625-638

  Denney, Jeffrey M ^a   Culhane, Jennifer F ^b   Goldenberg, Robert L ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Perinatal mortality; Prematurity; Preterm birth; Preterm delivery; Prevention

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; GESTAGEN; HYDROXYPROGESTERONE CAPROATE; MAGNESIUM SULFATE; MINERAL; OMEGA 3 FATTY ACID; PLACEBO; PROGESTERONE; RITODRINE; SURFACTANT; TERBUTALINE; UTERUS SPASMOLYTIC AGENT; VITAMIN;

ARTIFICIAL INSEMINATION; BABY; BRAIN HEMORRHAGE; CERCLAGE; CLINICAL TRIAL; DRUG USE; FETUS MATURITY; HIGH RISK POPULATION; HUMAN; INCIDENCE; LUNG DYSPLASIA; MOTHER; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NONHUMAN; OLIGOHYDRAMNIOS; PATENT DUCTUS ARTERIOSUS; PATIENT IDENTIFICATION; PATIENT SELECTION; PERINATAL CARE; PREGNANT WOMAN; PREMATURE LABOR; REVIEW; RISK FACTOR; UNITED STATES;

CERCLAGE, CERVICAL; EARLY DIAGNOSIS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PRENATAL CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 59349101888     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.6.625     Document Type: Review

References (144)

1. Goldenberg RL, Culhane JF, Iams J, Romero R: The epidemiology and etiology of preterm birth. Lancet 371, 75-84 (2008).
2. Robertson PA, Sniderman SH, Laros RK Jr et al.: Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am. J. Obstet. Gynecol. 166, 1629-1641 (1992).
3. Hamilton BE, Martin JA, Ventura SJ: Births: preliminary data for 2005. Natl Vital Stat. Rep. 55, 1-18 (2006).
4. Jenkins-Manning, Flenady V, Dodd J, Cincotta R, Crowther C: Care of women at risk of preterm birth: a survey of reported practice in Australia and New Zealand. Aust. NZ J. Obstet. Gynecol. 46(6), 546-548 (2006).
5. Morken N, Killen K, Hagberg H, Jacobsson B: Preterm birth in Sweden 1973-2001: rate, subgroups, and effect of changing patterns in multiple births, maternal age, and smoking: preterm delivery. Acta Obstet. Gynecol. Scand. 84(6), 558-565 (2005).
6. Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM: Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet. Gynecol. 105, 1084-1091 (2005).
7. Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I: Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. Br. Med. J. 332, 937-939 (2006).
8. Tracy SK, Tracy MB, Dean J, Laws P, Sullivan E: Spontaneous preterm birth of liveborn infants in women at low risk in Australia over 10 years: a population-based study. BJOG 114, 731-735 (2007).
9. Hack M, Fanaroff AA: Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum. Dev. 53, 193-218 (1999).
10. Tucker JM, Goldenberg RL, Davis RO, Copper RL, Winkler CL, Hauth JC: Etiologies of preterm birth in an indigent population: is prevention a logical expectation? Obstet. Gynecol. 77, 343-347 (1991).
11. Meis PJ, Goldenberg RL, Mercer BM et al.: The preterm prediction study: risk factors for indicated preterm births. Am. J. Obstet. Gynecol. 178, 562-567 (1998).
12. Bloom SL, Yost NP, McIntire DD, Leveno KJ: Recurrence of preterm birth in singleton and twin pregnancies. Obstet. Gynecol. 98, 379-385 (2001).
13. Goldenberg RL, Iams JD, Mercer BM et al.: The Preterm Prediction Study: the value of new vs. standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am. J. Public Health 88(2), 233-238 (1998).
14. Goldenberg RL, Mercer BM, Iams JD et al.: The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. NICHD Maternal-Fetal Medicine Units Network. Am. J. Obstet. Gynecol. 177, 8-12 (1997).
15. Goldenberg RL, Hauth JC, Andrews WW: Intrauterine infection and preterm delivery. N. Engl. J. Med. 342, 1500-1507 (2000).
16. Crowley PA: Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am. J. Obstet. Gynecol. 173, 322-335 (1995).
17. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr: Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet. Gynecol. 83, 483-494 (1994).
18. Paul RH, Koh KS, Monfared AH: Obstetric factors influencing outcome in infants weighing from 1,001 to 1,500 g. Am. J. Obstet. Gynecol. 133, 503-508 (1979).
19. Goldenberg RL: The prevention of low birthweight and its sequelae. Prev. Med. 23, 627-631 (1994).
20. Lorenz JM, Wooliever DE, Jetton JR, Paneth N: A quantitative review of mortality and developmental disability in extremely premature newborns. Arch. Pediatr. Adolesc. Med. 152, 425-435 (1998).
21. National Institutes of Health Consensus Development Statement: Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. Am. J. Obstet. Gynecol. 173, 246-252 (1994).
22. Hayes EJ, Paul DA, Stahl GE et al.: The effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet. Gynecol. 111, 921-926 (2008).
23. ACOG committee opinion: antenatal corticosteroid therapy for fetal maturation. American College of Obstetricians and Gynecologists. Obstet. Gynecol. 99, 871-873 (2002).
24. Lee BH, Stoll BJ, McDonald SA, Higgins RD: Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 117(5), 1503-1510 (2006).
25. Jobe AH, Soll R: Choice and dose of corticosteroid for antenatal treatments. Am. J. Obstet. Gyncecol. 190(4), 878-881 (2004).
26. Owen J, Goldenberg RL, Davis RO, Kirk KA, Copper RL: Evaluation of a risk scoring system as a predictor of preterm birth in an indigent population. Am. J. Obstet. Gynecol. 163, 873-879; erratum 2030 (1990).
27. Goldenberg RL, Iams JD, Mercer BM et al.: The Preterm Prediction Study: toward a multiple marker test for spontaneous preterm birth. Am. J. Obstet. Gynecol. 185(3), 643-651 (2001).
28. Goldenberg RL, Goepfert AR, Ramsey PS: Biochemical markers for the prediction of preterm birth. Am. J. Obstet. Gynecol. 192, S36-S46 (2005).
29. Moawad AH, Goldenberg RL, Mercer B et al.: The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am. J. Obstet. Gynecol. 186(5 Pt 1), 990-996 (2002).
30. Gravett MG, Novy MJ, Rosenfeld RG et al.: Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292, 462-469 (2004).
31. Gravett MG, Thomas A, Schneider KA et al.: Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J. Proteome Res. 6, 89-96 (2007).
32. Donaldson PJ, Billy JOG: The impact of prenatal care on birth weight: evidence from an international data set. Med. Care 22, 177-188 (1984).
33. Fink A, Yano EM, Goya D: Prenatal programs: what the literature reveals. Obstet. Gynecol. 80, 867-872 (1995).
34. Fiscella K: Does prenatal care improve birth outcomes? A critical review. Obstet. Gynecol. 85, 468-479 (1992).
35. Kogan MD, Alexander GR, Kotelchuck M, Nagey DA: Relation of the content of prenatal care to the risk of low birth weight: maternal reports of health behavior advice and initial prenatal care procedures. JAMA 271, 1340-1345 (1994).
36. McLaughlin FJ, Altemeier WA, Christensen MJ, Sherrod KB, Deitrich MS, Stern DT: Randomized trial of comprehensive prenatal care for low income women: effect on infant birth weight. Pediatrics 89, 128-132 (1992).
37. Hobel CJ, Ross MG, Bemis RL et al.: The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. Am. J. Obstet. Gynecol. 170, 54-62 (1994).
38. Collaborative Group on Preterm Birth Prevention: multicenter randomized, controlled trial of a preterm birth prevention program. Am. J. Obstet. Gynecol. 169, 352-366 (1993).
39. Berkowitz GS, Papiernik E: Epidemiology of preterm birth. Epidemiol. Rev. 15(2), 414-443 (1995).
40. Conde-Agudelo A, Rosas-Bermudez A, Kufury-Goeta AC: Birth spacing and risk of adverse perinatal outcomes: a metaanalysis. JAMA 295, 1809-1823 (2006).
41. Smith GC, Pell JP, Dobie R: Interpregnancy interval and the risk of preterm birth and neonatal death: retrospective cohort study. Br. Med. J. 327, 313 (2003).
42. Hendler I, Goldenberg RL, Mercer BM et al.: NICHD, Maternal-Fetal Medicine Units Network, Bethesda, MD: The Preterm Prediction Study: association between maternal body mass index (BMI) and spontaneous preterm birth. Am. J. Obstet. Gynecol. 192(3), 882-886 (2005).
43. Kramer MS: Effects of energy and protein intakes on pregnancy outcome: an overview of the research evidence from controlled clinical trials. Am. J. Clin. Nutr. 58, 627-635 (1993).
44. Rush D: Effects of changes in protein and calorie intake during pregnancy on the growth of the human fetus. In: Effective Care in Pregnancy and Childbirth (Volume 1). Chalmers I, Enkin MW, Keirse MJNC (Eds). Oxford University Press, Oxford, UK, 255-280 (1989).
45. Metcoff J, Costiloe P, Crosby WM et al.: Effect of food supplementation (WIC) during pregnancy on birth weight. Am. J. Clin. Nutr. 41, 933-947 (1985).
46. Neggers Y, Goldenberg RL: Some thoughts on body mass index, micronutrient intakes and pregnancy outcome. J. Nutr. 133, S1737-S1740 (2003).
47. Goldenberg RL: The plausibility of micronutrient deficiency in relationship to perinatal infection. J. Nutr. 133, S1645-S1648 (2003).
48. Goldenberg RL, Tamura T: Editorial. Prepregnancy weight and pregnancy outcome. JAMA 275(14), 1127-1128 (1996).
49. Prentice AM, Whitehead RG, Watkinson M, Lamb WH, Cole TJ: Prenatal dietary supplementation of African women and birth-weight. Lancet 1, 489-492 (1983).
50. Kramer MS, Kakuma R: Energy and protein intake in pregnancy. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD000032 (2003).
51. Lu ZM, Goldenberg RL, Cliver SP, Cutter GR, Blankson M: The relationship between maternal hematocrit and pregnancy outcome. Obstet. Gynecol. 77, 190-194 (1991).
52. Klebanoff MA, Shiono PH, Berendes HW, Rhoads GG: Facts and artifacts about anemia and preterm delivery. JAMA 262, 511-515 (1989).
53. Hemminki E, Rimpela U: A randomized comparison of routine versus selective iron supplementation during pregnancy. J. Am. Coll. Nutr. 10, 3-10 (1991).
54. Simmer K, Iles CA, James C, Thompson RPH: Are iron-folate supplements harmful? Am. J. Clin. Nutr. 45, 122-125 (1987).
55. Tamura T, Goldenberg RL: Zinc nutriture and pregnancy outcome. Nutr. Res. 16, 139-181 (1996).
56. Goldenberg RL, Tamura T, Neggers Y et al.: The effect of zinc supplementation on pregnancy outcome. JAMA 274, 463-468 (1995).
57. Simmer K, Lort-Phillips L, James C, Thompson RPH: A double-blind trial of zinc supplementation in pregnancy. Eur. J. Clin. Nutr. 45, 139-144 (1991).
58. Hofmeyr GJ, Atallah AN, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD001059.pub2 (2006).
59. Scholl TO, Hediger ML, Bendich A, Schall JI, Smith WK, Krueger PM: Use of multivitamin/mineral prenatal supplements: influence on the outcome of pregnancy. Am. J. Epidemiol. 146, 134-141 (1997).
60. Vahratian A, Siega-Riz AM, Savitz DA, Thorp JM: Multivitamin use and the risk of preterm birth. Am. J. Epidemiol. 160, 886-892 (2004).
61. Rumbold AR, Crowther CA, Haslam RR et al.: Vitamins C and E and the risks of preeclampsia and perinatal complications. N. Engl. J. Med. 354, 1796-1806 (2006).
62. Olsen SF, Secher NJ, Bjornsson S, Weber T, Atke A: The potential benefits of using fish oil in relation to preterm labor: the case for a randomized controlled trial? Acta Obstet. Gynecol. Scand. 82(11), 978-982 (2003).
63. Olsen S, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br. Med. J. 23(324), 447 (2002).
64. Olsen SF, Secher NJ, Tabor A, Weber T, Walker J, Gluud C: Randomized clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) team. BJOG 107(3), 382-395 (2000).
65. Offenbacher S, Boggess KA, Murtha AP et al.: Progressive periodontal disease and risk of very preterm delivery. Obstet. Gynecol. 107, 29-36 (2006). (7335).
66. Vergnes J, Sixou M: Preterm low birth weight and maternal periodontal status: a meta-analysis. Am. J. Obstet. Gynecol. 196, 135.E1-135.E7 (2007).
67. Vettore MV, Lamarca G, Leao ATT, Thomaz FB, Sheiham A, Leal M: Periodontal infection and adverse pregnancy outcomes: a systemic review of epidemiologic studies. Cad. Saude Publica. 22, 2041-2053 (2006).
68. Xiong X, Beukins P, Frasier WD, Beck J, Offenbacher S: Periodontal disease and adverse pregnancy outcomes: a systemic review. BJOG 113,135-143 (2006).
69. Goldenberg RL, Culhane JF: Preterm birth and periodontal disease. N. Engl. J. Med. 355, 18-19 (2006).
70. Michalowicz BS, Hodges JS, DiAngelis AJ et al.: Treatment of periodontal disease and the risk of preterm birth. N. Engl. J. Med. 355, 1885-1894 (2006).
71. Stamilio DM, Chang JJ, Macones GA: Periodontal disease and preterm birth: do the data have enough teeth to recommend screening and preventive treatment? Am. J. Obstet. Gynecol. 196, 93-94 (2007).
72. Pretorius C, Jagatt A, Lamont RF: The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J. Perinat. Med. 35, 93-99 (2007).
73. Haas JS, Fuentes-Afflick E, Stewart A et al.: Prepregnancy health status and the risk of preterm delivery. Arch. Pediatr. Adolesc. Med. 159, 58-63 (2005).
74. Johnson JWC, Austin KL, Jones GS, Davis GH, King TM: Efficacy of 17 α-hydroxyprogesterone caproate in the prevention of premature labor. N. Engl. J. Med. 293, 675-680 (1975).
75. Haluska GJ, Cook MJ, Novy MJ: Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys. Am. J. Obstet. Gynecol. 176, 682-691 (1997).
76. Elovitz M, Gonzalez J: Medroxyprogesterone acetate modulates the immune response in the uterus, cervix, and placenta in a mouse model of preterm birth. J. Matern. Fetal Neonatal Med. 21(4), 223-230 (2008).
77. Astle S, Slater DM, Thorton S: The involvement of progesterone in the onset of human labour. Eur. J. Obstet. Gynecol. Reprod. Biol. 108, 177-181 (2003).
78. Grazzini E, Guillon G, Monillac B, Zingg HH: Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509-512 (1998).
79. Meis PJ, Klebanoff M, Thom E et al.: Prevention of recurrent preterm delivery by 17 α-hydroxyprogesterone caproate. N. Engl. J. Med. 348, 2379-2385 (2003).
80. Fonesca EB, Celik E, Parra M, Singh M, Nicolaides KH; for the Fetal Medicine Foundation Second Trimester Screening Group: Progesterone and the risk of preterm birth among women with a short cervix. N. Engl. J. Med. 357, 462-469 (2007).
81. Dodd J, Flenady V, Cincotta R, Crowther C: Progesterone for the prevention of preterm birth: a systemic review. Obstet. Gynecol. 112(1), 127-134 (2008).
82. Borna S, Sahabi N: Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomized controlled trial. Aust. NZ J. Obstet. Gynaecol. 48, 58-63 (2008).
83. Rouse DJ, Caritis SN, Peaceman AM et al.: A trial of 17 α-hydroxyprogesterone caproate to prevent prematurity in twins. N. Engl. J. Med. 357, 454-461 (2007).
84. Hartikainen-Sorri A-L, Kauppila A, Tuimala R: Inefficacy of 17 α-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet. Gynecol. 56, 692-695 (1980).
85. ACOG Committee Opinion: use of progesterone to reduce preterm birth. American College of Obstetricians and Gynecologists. Obstet. Gynecol. 102, 1115-1116 (2003).
86. MRC/RCOG Working Party on Cervical Cerclage: Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage. Br. J. Obstet. Gynecol. 100, 516-523 (1993).
87. Althuisius SM, Dekker GA, van Geijn HP, Bekedam DJ, Hummel P: Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): study design and preliminary results. Am. J. Obstet. Gynecol. 183, 823-829 (2000).
88. Berghella V, Obido AO, To MS, Rust OA, Althiusius SM: Cerclage for short cervix on ultrasound: meta-analysis of trials using individual patient-level data. Obstet. Gynecol. 106, 181-189 (2005).
89. Sakai M, Shiozaki A, Tabata A et al.: Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am. J. Obstet. Gynecol. 194, 14-19 (2006).
90. Copper RL, Goldenberg RL, Davis RO et al.: Warning symptoms, uterine contractions, and cervical examination findings at risk of preterm delivery. Am. J. Obstet. Gynecol. 162, 748-754 (1990).
91. Collaborative Group on Preterm Birth Prevention: Multicenter randomized controlled trial of a preterm birth prevention program. Am. J. Obstet. Gynecol. 169, 352-366 (1993).
92. The Collaborative Home Uterine Monitoring Study Group: A multi-center randomized controlled trial of home uterine monitoring: active versus sham device. Am. J. Obstet. Gynecol. 173, 1120-1127 (1995).
93. Grimes DA, Schulz KF: Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet. Gynecol. 79, 137-142 (1992).
94. Dyson DC, Crites YM, Ray DA, Armstrong MA: Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am. J. Obstet. Gynecol. 164, 756-762 (1991).
95. Dyson DC, Danbe KH, Bamber JA et al.: Monitoring women at risk for preterm labor. N. Engl. J. Med. 338, 15-19 (1998).
96. Iams JD, Johnson FF, O'Shaughnessy RW: A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am. J. Obstet. Gynecol. 159, 595-603 (1988).
97. Higby K, Xenakis EMJ, Pauerstein CJ: Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am. J. Obstet. Gynecol. 168, 1247-1256 (1993).
98. Crowther CA, Hiller JE, Doyle LW: Magnesium sulfate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD001060 (2002).
99. Rouse DJ, Hirtz D, Thom E et al.: A randomized-controlled trial of magnesium sulfate for the prevention of cerebral palsy. N. Engl. J. Med. 359, 895-905 (2008).
100. Groome LJ, Goldenberg RL, Cliver SP, Davis RO, Copper RL; The March of Dimes Multicenter Study Group: Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am. J. Obstet. Gynecol. 167, 873-879 (1992).
101. Anotayanonth S, Subhedar NV, Neilson JP, Harigopal S: Betamimetics for inhibiting preterm labour. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD004352.pub2 (2004).
102. The Canadian Preterm Labor Investigators Group: Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N. Engl. J. Med. 327, 308-312 (1992).
103. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B: Calcium channel blockers for inhibiting preterm labor. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD002255 (2003).
104. Papatsonis, D, Flenady V, Cole S, Liley H: Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD004452.pub2 (2005).
105. King J, Flenady V, Cole S, Thorton S: Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst. Rev. DOI: 10.1002/14651858.CD001992.pub2 (2005).
106. Dudley DK, Hardie MJ: Fetal and neonatal effects of Indomethacin used as a tocolytic agent. Am. J. Obstet. Gynecol. 162, 549-554 (1990).
107. Eronen M, Pesonen E, Kurki T: Increased incidence of bronchopulmonary dysplasia after antenatal administration of Indomethacin to prevent preterm labor. J. Pediatr. 124, 782-788 (1994).
108. Norton ME, Merrill J, Cooper BA: Neonatal complications after the administration of Indomethacin for preterm labor. N. Engl. J. Med. 329, 1602-1607 (1993).
109. Amin SB, Sinkin RA, Glantz JC: Meta-analysis of the effect of antenatal Indomethacin on neonatal outcomes. Am. J. Obstet. Gynecol. 197, 486.E1-486.E10 (2007).
110. Atkinson MW, Goldenberg RL, Gaudier FL et al.: Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants. Am. J. Obstet. Gynecol. 173, 299-305 (1995).
111. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST: Bed rest in pregnancy. Obstet. Gynecol. 84, 131-136 (1994).
112. Freda MC, DeVore N: Should intravenous hydration be the first line of defense with threatened preterm labor? A critical review of the literature. J. Perinatol. 16, 385-389 (1996).
113. Maloni JA, Kasper CE: Physical and psychosocial effects of antepartum hospital bed rest: a review of the literature. Image J. Nurs. Sch. 23, 187-192 (1991).
114. Villar J, Farnot U, Barros F et al.: A randomized trial of psychosocial support during high-risk pregnancies. N. Engl. J. Med. 327, 1266-1271 (1992).
115. Haas DM: Preterm birth. Clin. Evid. 14, 1-20 (2005).
116. Goldenberg RL, Cliver SP, Mulvihill FX et al.: Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among Black women. Am. J. Obstet. Gynecol. 175, 1317-1324 (1996).
117. Copper RL, Goldenberg RL, Das A et al.: The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. Am. J. Obstet. Gynecol. 175, 1286-1292 (1996).
118. Floyd RL, Rimer BK, Giovino GA, Mullen PD, Sullivan SE: A review of smoking in pregnancy: effects on pregnancy outcomes and cessation efforts. Annu. Rev. Public Health 14, 379-411 (1993).
119. Windham G, Hopkins B, Fenster L, Swan S: Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 11(4), 427-433 (2000).
120. Albertsen K, Nybo Andersen A, Olsen J, Gronbaek M: Alcohol consumption during pregnancy and the risk of preterm delivery. Am. J. Epidemiol. 159, 155-161 (2004).
121. Lumley J, Oliver SS, Chamberlain C, Oakley L: Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst. Rev. DOI: 10.1002/14651858. CD001055.pub2 (2004).
122. Ricketts SA, Murray EK, Schwalberg R: Reducing low birth weight by resolving risks: results from Colorado's prenatal plus program. Am. J. Public Health 95, 1952-1957 (2005).
123. Peterson R, Garrett JM, Melvin CL, Hartmann KE: Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation. Tob. Control 15, 30-34 (2006).
124. Andrews WW, Goldenberg RL, Hauth JC: Preterm labor: emerging role of genital tract infections. Infect. Agents Dis. 4, 196-211 (1995).
125. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL: A review of premature birth and subclinical infection. Am. J. Obstet. Gynecol. 166, 1515-1528 (1992).
126. Fiscella K: Race, perinatal outcome, and amniotic infection. Obstet. Gynecol. Surv. 51, 60-66 (1996).
127. Yoon BH, Romero R, Park JS et al.: The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am. J. Obstet. Gynecol. 183, 1124-1129 (2000).
128. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N: Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J. Matern. Fetal Neonatal Med. 18, 241-247 (2005).
129. Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A: Markers of infection and their relationship to preterm delivery. Am. J. Perinatol. 12, 208-211 (1995).
130. Hillier SL, Nugent RP, Eschenbach DA et al.: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N. Engl. J. Med. 333, 1737-1742 (1995).
131. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N. Engl. J. Med. 333, 1732-1736 (1995).
132. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW: Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am. J. Obstet. Gynecol. 174, 1618-1621 (1996).
133. Kurkinen-Raty M, Vuopala S, Koskela M et al.: A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 107, 1427 (2000).
134. Lamont R: Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG 110(20), 71-75 (2003).
135. Ugwumadu A, Reid F, Hay P et al.: Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora. Obstet. Gynecol. 107, 863-868 (2006).
136. McDonald HM, Brocklehurst P, Gordon A: Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. DOI: 0.1002/14651858.CD000262.pub3 (2007).
137. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M: Meta-ana lysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet. Gynecol. 73, 576-582 (1989).
138. Smaill F: Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst. Rev. DOI: 10.1002/14651858. CD000490.pub2 (2001).
139. Goldenberg RL, Andrews WW, Yuan AC, MacKay HT, St Louis ME: Sexually transmitted diseases and adverse outcomes of pregnancy. Clin. Perinatol. 24, 23-41 (1997).
140. Mercer BM, Moretti ML, Prevost RR, Sibai BM: Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am. J. Obstet. Gynecol. 166, 794-802 (1992).
141. Ohlsson A: Treatments of preterm premature rupture of the membranes: a meta-analysis. Am. J. Obstet. Gynecol. 160, 890-906 (1989).
142. Mercer BM, Miodovnik M, Thurnau GR et al.: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 278, 989-995 (1997).
143. Kenyon SL, Taylor DJ, Tamow-Mordi W: Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. ORACLE Collaborative Group. Lancet 357, 979-988 (2001).
144. Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlison S, London SN: Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstet. Gynecol. 88, 801-805 (1996).